U.S. Construction Stock News

Recent analyst actions around Exelixis (EXEL) have put the stock back on many investors’ watchlists, as firms update ratings and earnings forecasts following its oncology pipeline progress. See our latest analysis for Exelixis. That renewed analyst interest sits against a mixed price backdrop, with a 7 day share price return of 9.75% and a 90 day share price return of 7.43% pointing to fading short term momentum. At the same time, the 3 year total shareholder return of 147.21% and 5 year...

Itron, Inc. recently expanded its UtilityIQ Application Suite to support new Cellular 500G and 500W modules for gas and water meters in the US, enabling utilities to combine cellular and mesh connectivity over its Gen6 network platform. A particularly important angle is that the upgraded, multi-transport headend and interoperable cellular modules let utilities mix vendors and deployment models without overhauling existing infrastructure. We’ll now examine how this enhanced cellular‑mesh...

Zimmer Biomet Holdings (ZBH) is drawing fresh attention after detailing plans to showcase robotics, AI-driven navigation tools and smart implant technology at the AAOS 2026 Annual Meeting in New Orleans. See our latest analysis for Zimmer Biomet Holdings. The recent product showcase around robotics, AI tools and smart implants comes after a 12.52% 1 month share price return and an 8.83% year to date share price return. However, the 1 year total shareholder return of 4.86% and 5 year total...

Upcoming earnings release and fleet expansion put Imperial Petroleum in focus Imperial Petroleum (IMPP) has drawn fresh attention after scheduling its Q4 and full-year 2025 results for March 6, 2026, along with plans to grow its fleet from 20 to 26 vessels. See our latest analysis for Imperial Petroleum. At a share price of US$4.10, Imperial Petroleum has seen a 16.15% 1 month share price return and a 12.33% year to date share price return. Its 1 year total shareholder return of 70.12%...

BeOne Medicines, listed as NasdaqGS:ONC, announced new collaborations with Amgen, Bristol Myers Squibb, and Novartis. The partnerships are focused on advancing BeOne Medicines' oncology therapy pipeline alongside its existing commercial products. The company also highlighted ongoing clinical trials that sit alongside these new pharma alliances. BeOne Medicines operates in oncology, an area where large pharma groups and smaller specialists often work together to bring new treatments through...

Kiniksa Pharmaceuticals International, plc recently reported past fourth-quarter and full-year 2025 results, with revenue rising to US$202.13 million for the quarter and US$677.56 million for the year, alongside a swing from a prior net loss to net income of US$14.2 million and US$59.01 million respectively. The company also filed a US$149.83 million shelf registration for employee share offerings and is set to present at TD Cowen’s 46th Annual Health Care Conference, underscoring how...

CHMP issued a negative opinion on ACADIA Pharmaceuticals' trofinetide marketing application for Rett syndrome in Europe. Acadia has requested a re examination of the opinion, triggering a formal review process. The decision affects prospects for European access to trofinetide and is drawing close attention from investors and patients. For investors watching NasdaqGS:ACAD, the regulatory setback comes with the stock trading around $22.5 and recent returns showing mixed signals. Shares are...

KeyCorp (NYSE:KEY) announced the resignation of Chief Information Officer Amy Brady for health reasons. Brady, a long-tenured technology leader at the bank, is stepping down as the company sets up an interim leadership structure. The transition plan includes reassignment of her responsibilities to maintain continuity in KeyCorp’s technology and operations. For a bank like KeyCorp, which operates across retail, commercial, and wealth management services, technology sits at the core of how it...

HNI (NYSE:HNI) has reported strong revenue growth tied to major acquisitions of Kimball and assets from Steelcase. The company has also reworked its portfolio through restructuring efforts and the divestiture of HNI India. These changes come as HNI absorbs integration costs while still reporting revenue that outpaced earlier expectations. For investors watching NYSE:HNI, the share price sits at $43.67, with a 3 year return of 60.6% and a 5 year return of 27.5%. Short term moves have been...

If you are wondering whether JPMorgan Chase at around US$300.26 is still reasonably priced or already baking in a lot of optimism, you are not alone. The stock has returned 1.0% over the last 7 days, a 1.8% decline over the past month, is down 7.7% year to date, yet shows a 22.4% return over 1 year and a 124.6% return over 5 years, which can change how investors think about both its growth potential and risk. Recent headlines have focused on JPMorgan Chase's position as a large US bank and...

Capital Clean Energy Carriers (CCEC) has just priced a €250 million unsecured bond offering in Greece, an event that reshapes its funding mix and near term financial flexibility for existing shareholders. See our latest analysis for Capital Clean Energy Carriers. At a share price of $23.08, Capital Clean Energy Carriers has seen an 11.87% 90 day share price return and a 13.07% year to date share price return. Its 1 year total shareholder return of 26.99% and 5 year total shareholder return of...

UroGen Pharma (NasdaqGM:URGN) reported durable complete response rates for ZUSDURI across all recurrence risk groups in its Phase 3 ENVISION trial in recurrent non muscle invasive bladder cancer. The company highlighted ZUSDURI as a non surgical option for patients with limited treatments today. Adoption of ZUSDURI is picking up following the activation of a permanent J code, which supports reimbursement and broader patient access. UroGen Pharma focuses on urologic cancers, where many...

United States Antimony recently completed an initial resource engineering study for its 100%-owned Fostung Tungsten Property in Ontario, confirming an inferred resource of 53.595 million pounds of tungsten trioxide and initiating plans to seek U.S. Government funding under the Defense Production Act to fast-track development for defense supply chains. This combination of a defined tungsten resource and a formal push for Defense Production Act support highlights the company’s expanding role...

Charter Communications (CHTR) has expanded its Spectrum Business offerings under California’s CALNET contract by adding Managed Network Services, Unified Communications with RingCentral, and new fiber connectivity options for state and local agencies. See our latest analysis for Charter Communications. Despite the CALNET expansion and recent leadership news, Charter’s 1-month and 3-month share price returns of 11.3% and 14.7% contrast with a 1-year total shareholder return decline of 37.7%...

In March 2026, Kroger expanded its Private Selection brand with more than 20 premium, globally inspired ready-to-eat and ready-to-cook meals, available exclusively across its family of stores and digital channels. This push into higher-quality, convenience-focused private label meals highlights how Kroger is leaning on differentiated own brands to keep value-conscious, time-pressed shoppers within its ecosystem as competition intensifies. We’ll now examine how this broadened Private...

Macy's (NYSE:M) has increased its regular quarterly dividend by 5%. The higher payout will apply to upcoming dividend distributions to shareholders. Macy's, trading around $18.28, is sending a clear signal about its priorities with this 5% dividend increase. The move comes after a mixed share price pattern, with a 7 day return of 12.2% decline and a 30 day return of 8.7% decline, but a 1 year return of 43.5%. For investors focused on income, the step up in the regular payout can be an...

U.S. Physical Therapy (USPH) is back in focus after reporting 2025 results that included higher net revenue and adjusted EBITDA, along with two new hospital affiliations that are expected to expand its clinic footprint from mid 2026. See our latest analysis for U.S. Physical Therapy. At a share price of US$83.25, U.S. Physical Therapy has posted a 10.4% 3 month share price return and a 7.3% 1 year total shareholder return, with longer term total returns still in decline. This suggests recent...

UDR (NYSE:UDR) has announced that its Chairman, President & CEO will present at Citi’s Miami Global Property CEO Conference. The appearance follows the company’s release of new investor materials and regulatory filings. The conference slot is expected to focus on UDR’s current disclosures, capital allocation priorities, and portfolio positioning. UDR is a multifamily real estate investment trust focused on apartment communities, a segment that often sits at the intersection of housing...

Viavi Solutions (NasdaqGS:VIAV) is introducing several new technologies at OFC 2026. Launches include a high density OSFP test platform for 1.6T Ethernet. The company is also unveiling new probe microscopes for hyperscale data centers. A distributed acoustic sensing product with real time AI and machine learning is being presented. Viavi Solutions operates in network testing, monitoring and assurance, with a focus on optical and high speed connectivity. The new OFC 2026 launches are aligned...

Allegiant Travel (NasdaqGS:ALGT) is working through supply chain related delays affecting its Boeing 737 MAX fleet modernization. The company has completed the sale of its Sunseeker Resort, sharpening its focus on the core airline business. These developments are reshaping Allegiant Travel's operational plans and capital priorities in 2026. Allegiant Travel, known for its leisure focused, low frequency route network, is refocusing on its airline operations as aircraft deliveries face timing...

In early March 2026, First American Financial reported that its Chief Financial Officer, Matthew Wajner, was named one of HousingWire’s 2026 Finance Leaders, highlighting his role in capital management and investment in data, technology, and artificial intelligence across the business. At the same time, the company’s profile as a dividend payer, with a multi-year pattern of increases and expectations for solid earnings, drew attention to how its finance leadership may be underpinning both...

If you are wondering whether Zscaler is attractively priced or already reflects high expectations, this breakdown is designed to help you frame that question clearly before you make any decisions. Zscaler shares last closed at US$154.67, with a return of 3.6% over the past 7 days, contrasted with declines of 22.7% over 30 days, 29.9% year to date, and 20.2% over the past year, while the 3 year return sits at 31.2% and the 5 year return at 14.7%. Recent coverage has focused on Zscaler's role...

3M recently reported Q4 2025 results, posting earnings per share of US$1.83 on revenue of US$6.02 billion, while also confirming it would appear at the J.P. Morgan Industrials Conference on March 17, 2026, with a live and archived webcast for investors. The combination of an earnings-per-share beat alongside a slight revenue shortfall, plus fresh commentary at a major conference, gives investors new information on how 3M’s operational progress and innovation focus are feeding through to...

Microchip Technology has opened registration for its 26th annual MASTERs Conference, a key technical training event for embedded design engineers. The conference focuses on hands on education, new products, and design techniques for Microchip’s ecosystem of tools and microcontrollers. Registration is now available to engineers, customers, and partners who want in depth sessions on embedded systems design. For investors tracking NasdaqGS:MCHP, this registration milestone highlights how...